Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.
- 2022-01
- RCT
- Oxidative medicine and cellular longevity 2022(1)
- Mehrdokht Mazdeh
- Parnaz Abolfathi
- Maryam Sabetghadam
- Younes Mohammadi
- Maryam Mehrpooya
- PubMed: 35936217
- DOI: 10.1155/2022/2493053
- High evidence
- Clinical
The percentage of patients with a favourable functional outcome at day 90, defined as mRS scores of 0 or 1, was significantly higher in the ALC group in comparison to the placebo group (52.9% versus 28.6%).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 1000 mg three times per day for three consecutive days